30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Treace Medical Concepts Inc (TMCI)

Track

Over the last 90 days, Treace Medical Concepts Inc. has seen significant insider buying, totaling $1.32 million, primarily driven by the CEO. There were no reported insider sales during this period. This activity coincides with a substantial stock price increase of over 175% in the past 90 days, and follows a recent earnings report where the company exceeded expectations.
Stock chart
Ticker: TMCI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Treace John T.
Chief Executive Officer
4 purchases — total 400,000 USD
Buy 11 Jun 2026
Value US$4,350,520.67 | Price 467.73 | Shares 52,691
Buy 11 Jun 2026
Value US$3,259,503.54 | Price 89.31 | Shares 75,086
Buy 11 Jun 2026
Value US$100,000.00 | Price 4.04 | Shares 1,000
Buy 11 Jun 2026
Value US$100,000.00 | Price 4.04 | Shares 1,000
Buy 10 Jun 2026
Value US$4,804,537.58 | Price 63.21 | Shares 51,191
Buy 10 Jun 2026
Value US$4,357,995.35 | Price 422.77 | Shares 76,071
Buy 1 Jun 2026
Value US$177,915.00 | Price 3.56 | Shares 50,000
Buy 28 May 2026
Value US$184,823.92 | Price 3.02 | Shares 61,202
Buy 27 May 2026
Value US$143,188.81 | Price 2.87 | Shares 49,810
Buy 26 May 2026
Value US$12,575.97 | Price 2.79 | Shares 4,508
Buy 14 May 2026
Value US$161,494.78 | Price 2.62 | Shares 61,750
Buy 13 May 2026
Value US$120,532.77 | Price 2.46 | Shares 49,013
Buy 12 May 2026
Value US$93,477.70 | Price 2.17 | Shares 43,000
Planned sale 17 Mar 2025
Value US$398,460.00 | Price 7.97 | Shares 50,000
Proposed sale 17 Mar 2025
Value US$397,500.00 | Price 7.95 | Shares 50,000
Buy 4 Mar 2025
Value US$524,064.00 | Price 8.73 | Shares 60,000
Buy 16 Sep 2024
Value US$265,630.00 | Price 5.31 | Shares 50,000
Buy 15 Aug 2024
Value US$501,034.80 | Price 5.96 | Shares 84,000
Buy 14 Aug 2024
Value US$510,314.50 | Price 6.00 | Shares 85,000
Buy 11 Jun 2024
Value US$264,600.00 | Price 5.88 | Shares 45,000
Buy 31 May 2024
Value US$151,327.50 | Price 6.05 | Shares 25,000
Buy 29 May 2024
Value US$130,062.50 | Price 5.20 | Shares 25,000
Buy 28 May 2024
Value US$253,475.00 | Price 5.07 | Shares 50,000
Buy 24 May 2024
Value US$93,501.00 | Price 5.19 | Shares 18,000
Buy 22 May 2024
Value US$60,424.98 | Price 4.99 | Shares 12,100
Buy 17 May 2024
Value US$556,170.00 | Price 5.56 | Shares 100,000
Buy 17 May 2024
Value US$556,170.00 | Price 5.56 | Shares 100,000
Buy 14 May 2024
Value US$100,000.84 | Price 5.17 | Shares 19,356
Buy 14 May 2024
Value US$767,805.00 | Price 5.12 | Shares 150,000
Buy 13 May 2024
Value US$683,490.00 | Price 4.56 | Shares 150,000
Buy 13 May 2024
Value US$161,089.71 | Price 4.38 | Shares 36,802
Buy 13 May 2024
Value US$657,981.00 | Price 4.54 | Shares 145,000
Buy 10 May 2024
Value US$112,567.50 | Price 4.50 | Shares 25,000
Buy 10 May 2024
Value US$594,620.00 | Price 4.57 | Shares 130,000
Buy 10 May 2024
Value US$686,880.00 | Price 4.58 | Shares 150,000
Buy 10 May 2024
Value US$379,848.79 | Price 4.57 | Shares 83,198
Buy 10 May 2024
Value US$376,023.20 | Price 4.53 | Shares 83,000
Proposed sale 14 Jun 2023
Value US$618,720.72 | Price 25.50 | Shares 24,266
Sale 5 Jun 2023
Value US$27,631,850.18 | Price 26.51 | Shares 1,042,318
Proposed sale 5 Jun 2023
Value US$27,631,850.18 | Price 26.51 | Shares 1,042,318
Sale 2 Jun 2023
Value US$1,285,814.53 | Price 26.51 | Shares 48,503
Proposed sale 2 Jun 2023
Value US$1,270,438.73 | Price 26.51 | Shares 47,923
Planned sale 16 May 2023
Value US$635,977.50 | Price 25.44 | Shares 25,000
Planned sale 1 May 2023
Value US$61,148.31 | Price 25.91 | Shares 2,360
Planned sale 1 May 2023
Value US$191,282.68 | Price 25.04 | Shares 7,640
Proposed sale 1 May 2023
Value US$252,023.00 | Price 25.20 | Shares 10,000
Planned sale 28 Apr 2023
Value US$1,000,264.00 | Price 25.01 | Shares 40,000
Planned sale 27 Apr 2023
Value US$294,031.00 | Price 25.35 | Shares 11,600
Planned sale 26 Apr 2023
Value US$414,012.20 | Price 25.55 | Shares 16,204
Proposed sale 26 Apr 2023
Value US$1,019,600.00 | Price 25.49 | Shares 40,000
Planned sale 12 Apr 2023
Value US$950,104.42 | Price 26.12 | Shares 36,370
Planned sale 11 Apr 2023
Value US$137,108.27 | Price 27.28 | Shares 5,026
Planned sale 11 Apr 2023
Value US$1,176,286.01 | Price 26.28 | Shares 44,764
Proposed sale 11 Apr 2023
Value US$2,630,000.00 | Price 26.30 | Shares 100,000
Planned sale 6 Apr 2023
Value US$105,121.23 | Price 26.00 | Shares 4,043
Planned sale 4 Apr 2023
Value US$409,667.03 | Price 26.00 | Shares 15,756
Planned sale 3 Apr 2023
Value US$5,226.00 | Price 26.00 | Shares 201
Planned sale 29 Mar 2023
Value US$820,425.33 | Price 25.28 | Shares 32,457
Planned sale 28 Mar 2023
Value US$656,649.54 | Price 25.02 | Shares 26,241
Planned sale 15 Mar 2023
Value US$1,151,665.00 | Price 23.03 | Shares 50,000
Planned sale 15 Mar 2023
Value US$142,955.62 | Price 22.87 | Shares 6,250
Planned sale 14 Mar 2023
Value US$218,533.08 | Price 23.25 | Shares 9,400
Planned sale 13 Mar 2023
Value US$26,708.94 | Price 24.73 | Shares 1,080
Planned sale 13 Mar 2023
Value US$200,288.19 | Price 24.07 | Shares 8,320
Sale 9 Mar 2023
Value US$50,650.75 | Price 24.41 | Shares 2,075
Planned sale 9 Mar 2023
Value US$39,052.00 | Price 26.00 | Shares 1,502
Sale 9 Mar 2023
Value US$17,892.53 | Price 24.41 | Shares 733
Sale 9 Mar 2023
Value US$10,032.51 | Price 24.41 | Shares 411
Sale 9 Mar 2023
Value US$12,327.05 | Price 24.41 | Shares 505
Sale 9 Mar 2023
Value US$4,320.57 | Price 24.41 | Shares 177
Sale 9 Mar 2023
Value US$25,386.40 | Price 24.41 | Shares 1,040
Planned sale 8 Mar 2023
Value US$480,002.00 | Price 24.00 | Shares 20,000
Planned sale 8 Mar 2023
Value US$562,500.00 | Price 22.50 | Shares 25,000
Planned sale 1 Mar 2023
Value US$1,067,545.00 | Price 21.35 | Shares 50,000
Planned sale 1 Mar 2023
Value US$270,930.24 | Price 21.36 | Shares 12,684
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-11 2026-06-11 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
52,691 -22.6%
467.73
US$4,350,521 		52,691 -22.6% 467.73 US$4,350,521
2026-06-11 2026-06-11 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
75,086 +7.1%
89.31
US$3,259,504 		75,086 +7.1% 89.31 US$3,259,504
2026-06-11 2026-06-11 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
24,220 -27.0%
152.16
US$1,122,543 		24,220 -27.0% 152.16 US$1,122,543
2026-06-11 2026-06-11 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
1,000 +0.3%
4.04
US$100,000 		1,000 +0.3% 4.04 US$100,000
2026-06-11 2026-06-10 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
1,000 +0.4%
4.02
US$100,000 		1,000 +0.4% 4.02 US$100,000
2026-06-11 2026-06-10 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
1,000 +0.4%
4.02
US$100,000 		1,000 +0.4% 4.02 US$100,000
2026-06-01 2026-06-01 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
50,000 +0.7%
3.56
US$177,915 		50,000 +0.7% 3.56 US$177,915
2026-05-28 2026-05-28 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
61,202 +0.8%
3.02
US$184,824 		61,202 +0.8% 3.02 US$184,824
2026-05-28 2026-05-27 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
49,810 +0.7%
2.87
US$143,189 		49,810 +0.7% 2.87 US$143,189
2026-05-28 2026-05-26 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
4,508 +0.1%
2.79
US$12,576 		4,508 +0.1% 2.79 US$12,576
2026-05-14 2026-05-14 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
61,750 +0.9%
2.62
US$161,495 		61,750 +0.9% 2.62 US$161,495
2026-05-14 2026-05-13 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
49,013 +0.7%
2.46
US$120,533 		49,013 +0.7% 2.46 US$120,533
2026-05-14 2026-05-12 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
43,000 +0.6%
2.17
US$93,478 		43,000 +0.6% 2.17 US$93,478
2025-03-19 2025-03-17 PlS Planned sale
1.4
Scanlan Sean F.

Chief Innovation Officer

Officer
50,000 -12.1%
7.97
US$398,460 		50,000 -12.1% 7.97 US$398,460
2025-03-17 2025-03-17 PrS Proposed sale
1.4
SEAN SCANLAN

Officer

Officer
50,000
7.95
US$397,500 		50,000 7.95 US$397,500
2025-03-04 2025-03-04 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
60,000 +0.9%
8.73
US$524,064 		60,000 +0.9% 8.73 US$524,064
2024-09-17 2024-09-16 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
50,000 +0.8%
5.31
US$265,630 		50,000 +0.8% 5.31 US$265,630
2024-08-19 2024-08-15 B Purchase
3.8
TREACE JAMES T
Non-Executive Director
84,000 +7.4%
5.96
US$501,035 		84,000 +7.4% 5.96 US$501,035
2024-08-15 2024-08-14 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
85,000 +1.3%
6.00
US$510,314 		85,000 +1.3% 6.00 US$510,314
2024-06-11 2024-06-11 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
45,000 +0.7%
5.88
US$264,600 		45,000 +0.7% 5.88 US$264,600
2024-06-03 2024-05-31 B Purchase
3.8
TREACE JAMES T
Non-Executive Director
25,000 +2.2%
6.05
US$151,328 		25,000 +2.2% 6.05 US$151,328
2024-05-30 2024-05-29 B Purchase
3.8
TREACE JAMES T
Non-Executive Director
25,000 +2.3%
5.20
US$130,062 		25,000 +2.3% 5.20 US$130,062
2024-05-29 2024-05-28 B Purchase
3.8
TREACE JAMES T
Non-Executive Director
50,000 +4.8%
5.07
US$253,475 		50,000 +4.8% 5.07 US$253,475
2024-05-28 2024-05-24 B Purchase
3.6
MOTT RICHARD W
Non-Executive Director
18,000 +1.7%
5.19
US$93,501 		18,000 +1.7% 5.19 US$93,501
2024-05-23 2024-05-22 B Purchase
3.6
MOTT RICHARD W
Non-Executive Director
12,100 +1.2%
4.99
US$60,425 		12,100 +1.2% 4.99 US$60,425
2024-05-20 2024-05-17 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
100,000 +1.6%
5.56
US$556,170 		100,000 +1.6% 5.56 US$556,170
2024-05-20 2024-05-17 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
100,000 +1.6%
5.56
US$556,170 		100,000 +1.6% 5.56 US$556,170
2024-05-14 2024-05-14 B Purchase
2.9
Kiernan Jane E
Non-Executive Director
19,356 +346.6%
5.17
US$100,001 		19,356 +346.6% 5.17 US$100,001
2024-05-14 2024-05-14 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
150,000 +2.5%
5.12
US$767,805 		150,000 +2.5% 5.12 US$767,805
2024-05-13 2024-05-13 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
150,000 +2.5%
4.56
US$683,490 		150,000 +2.5% 4.56 US$683,490
2024-05-13 2024-05-13 B Purchase
3.6
MOTT RICHARD W
Non-Executive Director
36,802 +3.7%
4.38
US$161,090 		36,802 +3.7% 4.38 US$161,090
2024-05-13 2024-05-13 B Purchase
3.8
TREACE JAMES T
Non-Executive Director
145,000 +16.2%
4.54
US$657,981 		145,000 +16.2% 4.54 US$657,981
2024-05-13 2024-05-10 B Purchase
3.2
Jain Deepti
Non-Executive Director
25,000 +401.0%
4.50
US$112,568 		25,000 +401.0% 4.50 US$112,568
2024-05-13 2024-05-10 B Purchase
3.2
BAKEWELL JOHN K
Non-Executive Director
130,000 +2575.3%
4.57
US$594,620 		130,000 +2575.3% 4.57 US$594,620
2024-05-13 2024-05-10 B Purchase
3.2
Treace John T.

Chief Executive Officer

Executive Director Large shareholder
150,000 +2.6%
4.58
US$686,880 		150,000 +2.6% 4.58 US$686,880
2024-05-13 2024-05-10 B Purchase
3.6
MOTT RICHARD W
Non-Executive Director
83,198 +9.2%
4.57
US$379,849 		83,198 +9.2% 4.57 US$379,849
2024-05-13 2024-05-10 B Purchase
3.8
TREACE JAMES T
Non-Executive Director
83,000 +10.2%
4.53
US$376,023 		83,000 +10.2% 4.53 US$376,023
2023-06-14 2023-06-14 PrS Proposed sale
TIMBIE THOMAS E

Director

Non-Executive Director
24,266
25.50
US$618,721 		24,266 25.50 US$618,721
2023-06-08 2023-06-05 S Sale
3.5
BAYS F BARRY

Former Director
1,042,318 -100.0%
26.51
US$27,631,850 		1,042,318 -100.0% 26.51 US$27,631,850
2023-06-05 2023-06-05 PrS Proposed sale
3.5
F. Barry Bays

Other: Former Board Member
1,042,318
26.51
US$27,631,850 		1,042,318 26.51 US$27,631,850
2023-06-08 2023-06-02 S Sale
3.5
BAYS F BARRY

Former Director
48,503 -4.4%
26.51
US$1,285,815 		48,503 -4.4% 26.51 US$1,285,815
2023-06-02 2023-06-02 PrS Proposed sale
3.5
F. Barry Bays

Other: Former Board Member
47,923
26.51
US$1,270,439 		47,923 26.51 US$1,270,439
2023-05-18 2023-05-16 PlS Planned sale
1.4
Scanlan Sean F.

Chief Innovation Officer

Officer
25,000 -43.6%
25.44
US$635,978 		25,000 -43.6% 25.44 US$635,978
2023-05-02 2023-05-01 PlS Planned sale
3.8
TREACE JAMES T
Non-Executive Director
2,360 -0.3%
25.91
US$61,148 		2,360 -0.3% 25.91 US$61,148
2023-05-02 2023-05-01 PlS Planned sale
3.8
TREACE JAMES T
Non-Executive Director
7,640 -0.9%
25.04
US$191,283 		7,640 -0.9% 25.04 US$191,283
2023-05-01 2023-05-01 PrS Proposed sale
3.8
TREACE JAMES T

Director

Non-Executive Director
10,000
25.20
US$252,023 		10,000 25.20 US$252,023
2023-05-02 2023-04-28 PlS Planned sale
3.8
TREACE JAMES T
Non-Executive Director
40,000 -4.4%
25.01
US$1,000,264 		40,000 -4.4% 25.01 US$1,000,264
2023-04-28 2023-04-27 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
11,600 -1.1%
25.35
US$294,031 		11,600 -1.1% 25.35 US$294,031
2023-04-28 2023-04-26 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
16,204 -1.4%
25.55
US$414,012 		16,204 -1.4% 25.55 US$414,012
2023-04-26 2023-04-26 PrS Proposed sale
3.5
F. Barry Bays

Other: Board Member
40,000
25.49
US$1,019,600 		40,000 25.49 US$1,019,600
2023-04-13 2023-04-12 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
36,370 -3.1%
26.12
US$950,104 		36,370 -3.1% 26.12 US$950,104
2023-04-13 2023-04-11 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
5,026 -0.4%
27.28
US$137,108 		5,026 -0.4% 27.28 US$137,108
2023-04-13 2023-04-11 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
44,764 -3.7%
26.28
US$1,176,286 		44,764 -3.7% 26.28 US$1,176,286
2023-04-11 2023-04-11 PrS Proposed sale
3.5
F. Barry Bays Revocable Trust U/A 11/11/14

Board Member
100,000
26.30
US$2,630,000 		100,000 26.30 US$2,630,000
2023-04-10 2023-04-06 PlS Planned sale
3.6
MOTT RICHARD W
Non-Executive Director
4,043 -0.4%
26.00
US$105,121 		4,043 -0.4% 26.00 US$105,121
2023-04-05 2023-04-04 PlS Planned sale
3.6
MOTT RICHARD W
Non-Executive Director
15,756 -1.7%
26.00
US$409,667 		15,756 -1.7% 26.00 US$409,667
2023-04-05 2023-04-03 PlS Planned sale
3.6
MOTT RICHARD W
Non-Executive Director
201 -0.0%
26.00
US$5,226 		201 -0.0% 26.00 US$5,226
2023-03-30 2023-03-29 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
32,457 -2.6%
25.28
US$820,425 		32,457 -2.6% 25.28 US$820,425
2023-03-30 2023-03-28 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
26,241 -2.1%
25.02
US$656,650 		26,241 -2.1% 25.02 US$656,650
2023-03-17 2023-03-15 PlS Planned sale
TIMBIE THOMAS E
Non-Executive Director
50,000 -4.2%
23.03
US$1,151,665 		50,000 -4.2% 23.03 US$1,151,665
2023-03-17 2023-03-15 PlS Planned sale
1.4
Owens Daniel E.

Chief Human Resources Officer
6,250 -16.8%
22.87
US$142,956 		6,250 -16.8% 22.87 US$142,956
2023-03-15 2023-03-14 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
9,400 -0.7%
23.25
US$218,533 		9,400 -0.7% 23.25 US$218,533
2023-03-15 2023-03-13 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
1,080 -0.1%
24.73
US$26,709 		1,080 -0.1% 24.73 US$26,709
2023-03-15 2023-03-13 PlS Planned sale
3.5
BAYS F BARRY
Non-Executive Director
8,320 -0.6%
24.07
US$200,288 		8,320 -0.6% 24.07 US$200,288
2023-03-10 2023-03-09 S Sale
3.2
Treace John T.

Chief Executive Offer

Executive Director Large shareholder
2,075 -0.0%
24.41
US$50,651 		2,075 -0.0% 24.41 US$50,651
2023-03-10 2023-03-09 PlS Planned sale
3.6
MOTT RICHARD W
Non-Executive Director
1,502 -0.1%
26.00
US$39,052 		1,502 -0.1% 26.00 US$39,052
2023-03-10 2023-03-09 S Sale
2.5
Berutti Aaron

Sr. VP, Sales

Officer
733 -5.3%
24.41
US$17,893 		733 -5.3% 24.41 US$17,893
2023-03-10 2023-03-09 S Sale
1.4
Owens Daniel E.

Chief Human Resources Officer
411 -3.8%
24.41
US$10,033 		411 -3.8% 24.41 US$10,033
2023-03-10 2023-03-09 S Sale
1.4
Scanlan Sean F.

Chief Innovation Officer

Officer
505 -5.1%
24.41
US$12,327 		505 -5.1% 24.41 US$12,327
2023-03-10 2023-03-09 S Sale
2.4
Elder Scot Michael

*See "Remarks"

Officer
177 -0.8%
24.41
US$4,321 		177 -0.8% 24.41 US$4,321
2023-03-10 2023-03-09 S Sale
2.7
Hair Mark

Chief Financial Officer

Officer
1,040 -3.7%
24.41
US$25,386 		1,040 -3.7% 24.41 US$25,386
2023-03-10 2023-03-08 PlS Planned sale
3.6
MOTT RICHARD W
Non-Executive Director
20,000 -1.9%
24.00
US$480,002 		20,000 -1.9% 24.00 US$480,002
2023-03-10 2023-03-08 PlS Planned sale
3.6
MOTT RICHARD W
Non-Executive Director
25,000 -2.3%
22.50
US$562,500 		25,000 -2.3% 22.50 US$562,500
2023-03-03 2023-03-01 PlS Planned sale
3.6
MOTT RICHARD W
Non-Executive Director
50,000 -4.3%
21.35
US$1,067,545 		50,000 -4.3% 21.35 US$1,067,545
2023-03-02 2023-03-01 PlS Planned sale
3.8
TREACE JAMES T
Non-Executive Director
12,684 -1.3%
21.36
US$270,930 		12,684 -1.3% 21.36 US$270,930
Explore more

More insider trading research around Treace Medical Concepts Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America